Literature DB >> 19234357

Optic neuritis in different strains of mice by a recombinant HSV-1 expressing murine interleukin-2.

Mandana Zandian1, Raelene Belisle, Kevin R Mott, Steven Nusinowitz, Florence M Hofman, Homayon Ghiasi.   

Abstract

PURPOSE: The authors have shown previously that a recombinant HSV-1 that constitutively expresses two copies of murine IL-2 (HSV-IL-2) induces demyelination by activated CD8(+) T cells in the brain and spinal cord of ocularly infected female BALB/c mice. The present study was conducted to determine whether the ocular infection with this recombinant virus induces optic neuritis independent of virus dose, major histocompatibility complex (MHC) background, or sex.
METHODS: Female BALB/c, C57BL/6, SJL/6, and 129SVE mice and male BALB/c mice were ocularly infected with different doses of recombinant HSV-IL-2 virus. Demyelination of optic nerves in infected mice was monitored histologically using Luxol fast blue staining and by measurement of visual-evoked cortical potentials (VECPs).
RESULTS: Both focal and diffuse regions of demyelination of the optic nerves were observed in the HSV-IL-2-infected mice as early as day 10 after infection and as late as day 60 after infection (the final experimental time point) in all strains of mice tested. Optic nerve demyelination was not observed in control mice ocularly infected with HSV-IL-4 or wild-type HSV-1. VECP responses were delayed significantly in the HSV-IL-2-infected mice compared with mice infected with control viruses.
CONCLUSIONS: The results demonstrate for the first time that a combination of viral infection and constitutive expression of IL-2, but not IFN-gamma or IL-4, can result in demyelination and visual impairment in the optic nerves of ocularly infected mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234357      PMCID: PMC6217944          DOI: 10.1167/iovs.08-3211

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  58 in total

1.  CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.

Authors:  Yanira Osorio; Scott F La Point; Steve Nusinowitz; Florence M Hofman; Homayon Ghiasi
Journal:  Exp Neurol       Date:  2005-05       Impact factor: 5.330

2.  In vitro promoter activity associated with the latency-associated transcript gene of herpes simplex virus type 1.

Authors:  J Zwaagstra; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

Review 3.  Ocular viral infections.

Authors:  D Pavan-Langston
Journal:  Med Clin North Am       Date:  1983-09       Impact factor: 5.456

4.  Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.

Authors:  Homayon Ghiasi; Yanira Osorio; Yahya Hedvat; Guey Chuen Perng; Anthony B Nesburn; Steven L Wechsler
Journal:  Virology       Date:  2002-10-10       Impact factor: 3.616

5.  Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests.

Authors:  A Ghezzi; V Martinelli; V Torri; M Zaffaroni; M Rodegher; G Comi; A Zibetti; N Canal
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

6.  Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in mice.

Authors:  H Ghiasi; Y Osorio; G C Perng; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration.

Authors:  Y Akwa; D E Hassett; M L Eloranta; K Sandberg; E Masliah; H Powell; J L Whitton; F E Bloom; I L Campbell
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

8.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.

Authors:  I L Campbell; C R Abraham; E Masliah; P Kemper; J D Inglis; M B Oldstone; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Immune responses in interleukin-2-deficient mice.

Authors:  T M Kündig; H Schorle; M F Bachmann; H Hengartner; R M Zinkernagel; I Horak
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

10.  Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity.

Authors:  Homayon Ghiasi; Yanira Osorio; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  15 in total

1.  Visual abnormalities associated with enhanced optic nerve myelination.

Authors:  Minzhong Yu; S Priyadarshini Narayanan; Feng Wang; Emily Morse; Wendy B Macklin; Neal S Peachey
Journal:  Brain Res       Date:  2010-12-21       Impact factor: 3.252

2.  Aging-related changes of optic nerve of Wistar albino rats.

Authors:  Hassan I H El-Sayyad; Soad A Khalifa; Fawkia I El-Sayyad; Asma S Al-Gebaly; Ahmed A El-Mansy; Ezaldin A M Mohammed
Journal:  Age (Dordr)       Date:  2013-09-01

3.  Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.

Authors:  Gregory F Wu; Chelsea R Parker Harp; Kenneth S Shindler
Journal:  Curr Immunol Rev       Date:  2015

4.  Impact of a Demyelination-Inducing Central Nervous System Virus on Expression of Demyelination Genes in Type 2 Lymphoid Cells.

Authors:  Satoshi Hirose; Mihoko Kato; Kati Tormanen; Pedram Shafiei Jahani; Omid Akbari; Homayon Ghiasi
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

5.  Role of interleukin-2 and herpes simplex virus 1 in central nervous system demyelination in mice.

Authors:  Kevin R Mott; Mandana Zandian; Sariah J Allen; Homayon Ghiasi
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

6.  Macrophage IL-12p70 signaling prevents HSV-1-induced CNS autoimmunity triggered by autoaggressive CD4+ Tregs.

Authors:  Kevin R Mott; David Gate; Mandana Zandian; Sariah J Allen; Naveen Kumar Rajasagi; Nico van Rooijen; Shuang Chen; Moshe Arditi; Barry T Rouse; Richard A Flavell; Terrence Town; Homayon Ghiasi
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-08       Impact factor: 4.799

7.  Ocular infection of mice with an avirulent recombinant HSV-1 expressing IL-4 and an attenuated HSV-1 strain generates virulent recombinants in vivo.

Authors:  Kevin R Mott; Steven L Wechsler; Homayon Ghiasi
Journal:  Mol Vis       Date:  2010-10-26       Impact factor: 2.367

8.  IL-2 suppression of IL-12p70 by a recombinant HSV-1 expressing IL-2 induces T-cell auto-reactivity and CNS demyelination.

Authors:  Mandana Zandian; Kevin R Mott; Sariah J Allen; Shuang Chen; Moshe Arditi; Homayon Ghiasi
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

9.  Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2.

Authors:  M Zandian; K R Mott; S J Allen; O Dumitrascu; J Z Kuo; H Ghiasi
Journal:  Gene Ther       Date:  2011-03-17       Impact factor: 5.250

10.  Deep sequencing for the detection of virus-like sequences in the brains of patients with multiple sclerosis: detection of GBV-C in human brain.

Authors:  John D Kriesel; Maurine R Hobbs; Brandt B Jones; Brett Milash; Rashed M Nagra; Kael F Fischer
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.